Supply-Demand

Supply

Evidence-based clinical software used in Clinical Decision Support

-- 135046

  • Time: 2014-01-10 14:45:29
  • View: 5543

Intellectual Property: U.S. and Canadian patent applications filed July 25, 2008

Market Size: U.S. .5 billion

Development Stage:

Beta prototype developed, first pilot site implementation underway. Global 22 site 

randomized clinical study in progress 

Major Milestone: Commercial product Fall 2012

Bedside Clinical Systems (BCS)  was created in 2011 in Toronto in two purposes: 

1. Mobilize innovative best practices in paediatric healthcare;

2. Empower frontline clinicians with the information they need to provide better care for children。

Paediatric healthcare professionals worldwide look to BCS for the solutions that will help support their workflow needs and identify critically-ill children before their condition deteriorates. The solutions developed at BCS offer paediatric healthcare professionals the edge they need to predict a child’s condition and intervene to avert a Code Blue incident.

BCS is founded on the principles of reducing costs for hospitals while helping clinicians provide better care for children.

Hospital ROI:

The BedPEWS system pays for itself by eliminating the costs associated with code-blue events and intensive care; BCS estimates hospitals will break-even after averting two code-blue events. In addition to the cost savings, implementing the BedPEWS system significantly reduces death and health complications for child patients. This system allows clinicians to focus on critically-ill children while providing parents with the peace of mind that their child is being monitored by the very best early-warning innovation.

 

Copyright(C)2013 www.chinaworth.net All Rights Reserved 京ICP备13015857号-1